Minimal Change Disease Secondary to Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplant for Myelodysplastic Syndrome.

Elghawy, Omar; Wang, John S; Hafey, Alexander C; Renaghan, Amanda D; Whitehair, Rachel M; Kindwall-Keller, Tamila L

Elghawy, Omar; Wang, John S; Hafey, Alexander C; Renaghan, Amanda D; Whitehair, Rachel M; Kindwall-Keller, Tamila L.

Afiliação

Elghawy O; School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Wang JS; School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Hafey AC; School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Renaghan AD; Division of Nephrology, University of Virginia, Charlottesville, Virginia, USA.
Whitehair RM; Department of Pathology, University of Virginia, Charlottesville, Virginia, USA.
Kindwall-Keller TL; Division of Hematology and Oncology, University of Virginia, Charlottesville, Virginia, USA.

Case Rep Nephrol Dial ; 12(1): 31-37, 2022.

Article em En | MEDLINE | ID: mdl-35433844

Palavras-chave

Allogeneic hematopoietic cell transplant; Graft-versus-host disease; Kidney biopsy; Minimal change disease; Nephrotic syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Case Rep Nephrol Dial Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google